In fact increased MCJ expression has been reported in NAFLD patients, while reduction of liver steatosis and fibrosis were observed in MCJ-deficient mouse NASH models.290. This evidence concerns the gene DNAJC15 and metabolic dysfunction-associated steatotic liver disease.